Class information for:
Level 1: RASAGILINE//SELEGILINE//DEPRENYL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
7543 1276 40.7 66%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1316 8028 RASAGILINE//SELEGILINE//DEPRENYL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RASAGILINE Author keyword 199 77% 11% 137
2 SELEGILINE Author keyword 181 59% 16% 201
3 DEPRENYL Author keyword 120 55% 12% 149
4 L DEPRENYL Author keyword 77 72% 5% 60
5 DEPRENYL SELEGILINE Author keyword 21 85% 1% 11
6 DESMETHYLSELEGILINE Author keyword 20 100% 1% 9
7 EVE TOPF Address 11 69% 1% 9
8 TV3326 Author keyword 9 83% 0% 5
9 LADOSTIGIL Author keyword 8 70% 1% 7
10 NPF Address 8 70% 1% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RASAGILINE 199 77% 11% 137 Search RASAGILINE Search RASAGILINE
2 SELEGILINE 181 59% 16% 201 Search SELEGILINE Search SELEGILINE
3 DEPRENYL 120 55% 12% 149 Search DEPRENYL Search DEPRENYL
4 L DEPRENYL 77 72% 5% 60 Search L+DEPRENYL Search L+DEPRENYL
5 DEPRENYL SELEGILINE 21 85% 1% 11 Search DEPRENYL+SELEGILINE Search DEPRENYL+SELEGILINE
6 DESMETHYLSELEGILINE 20 100% 1% 9 Search DESMETHYLSELEGILINE Search DESMETHYLSELEGILINE
7 TV3326 9 83% 0% 5 Search TV3326 Search TV3326
8 LADOSTIGIL 8 70% 1% 7 Search LADOSTIGIL Search LADOSTIGIL
9 ENHANCER SUBSTANCES 8 100% 0% 5 Search ENHANCER+SUBSTANCES Search ENHANCER+SUBSTANCES
10 ALIPHATIC PROPARGYLAMINES 6 80% 0% 4 Search ALIPHATIC+PROPARGYLAMINES Search ALIPHATIC+PROPARGYLAMINES

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DEPRENYL 249 60% 21% 269
2 L DEPRENYL 174 57% 16% 206
3 SELEGILINE 100 44% 14% 173
4 DEPRENYL SELEGILINE 56 71% 4% 45
5 OXIDASE B INHIBITORS 55 87% 2% 27
6 MAO B INHIBITOR 52 70% 3% 43
7 ANTI PARKINSON DRUG 46 67% 3% 42
8 MAO B 45 37% 8% 96
9 PROPAGATION MEDIATED RELEASE 38 93% 1% 14
10 SELECTIVE ENHANCER 37 100% 1% 14

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa 2000 96 9 100%
Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity 2010 51 100 63%
Rasagiline A Review of its Use in the Treatment of Idiopathic Parkinson's Disease 2012 18 46 72%
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease 2007 71 81 70%
Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease A Review of Symptomatic and Potential Disease-Modifying Effects 2011 28 67 66%
THE PHARMACOLOGY OF SELEGILINE 2011 17 59 80%
The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline 2010 21 61 79%
Rasagiline in Parkinson's disease: A review based on meta-analysis of clinical data 2013 6 40 70%
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release 2014 18 158 25%
Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimer's Disease Treatment 2012 22 130 38%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EVE TOPF 11 69% 0.7% 9
2 NPF 8 70% 0.5% 7
3 NPF NEURODEGENERAT DIS 6 80% 0.3% 4
4 EVE TOPF NPF 6 100% 0.3% 4
5 R P ORT FAMILY 5 33% 1.0% 13
6 EVE TOPF NEURODEGENERAT DIS 4 40% 0.6% 8
7 EVE TOPF EXCELLENCE NEURODEGENERAT DIS 3 29% 0.8% 10
8 EVE TOPF USA PARKINSON FDN EXCELLENCE 3 43% 0.5% 6
9 CENT ISOTOPE 3 31% 0.7% 9
10 BASIC GERONTOL 3 15% 1.3% 16

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000212580 MONOAMINE OXIDASE//MAO B//MONOAMINE OXIDASE B
2 0.0000149400 MOCLOBEMIDE//ATYPICAL DEPRESSION//BROFAROMINE
3 0.0000117756 MOTOR FLUCTUATIONS//LEVODOPA//DYSKINESIA
4 0.0000103249 MPTP//MPP//1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE
5 0.0000087006 NEUROMELANIN//AMINOCHROME//5 S CYSTEINYLDOPAMINE
6 0.0000073860 3 IODOTHYRONAMINE//BETA PHENYLETHYLAMINE//TRACE AMINES
7 0.0000053945 MCCS HMP PA BRANCH//FENPROPOREX//CLIN SQUADRON
8 0.0000051382 MOL CELLULAR TOXICOL HUMAN PLICAT//OULU CITY HOSP//DOOR TO DOOR SURVEYS
9 0.0000050984 SALSOLINOL//NORSALSOLINOL//1 METHYL 1 2 3 4 TETRAHYDROISOQUINOLINE
10 0.0000050048 PLATELET MONOAMINE OXIDASE//PLATELET MAO//PLATELET MAO ACTIVITY